The nominal deal value is $236M, and the buyout price is a 40% premium to Friday’s close.
SLTM has a motley collection of medical devices for cosmetic applications, including the Thermage radio-frequency system for skin tightening (originally owned by THRM) and the Lipisonix “body contouring” system (originally owned by MRX).
*The preeminent biotech “roll-up” company.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”